您的位置: 专家智库 > >

国家自然科学基金(30570885)

作品数:3 被引量:155H指数:2
相关作者:翁建平余秋琼严晋华沈云峰梁华更多>>
相关机构:中山大学附属第三医院中山大学更多>>
发文基金:国家自然科学基金教育部“新世纪优秀人才支持计划”国家教育部博士点基金更多>>
相关领域:医药卫生生物学更多>>

文献类型

  • 3篇中文期刊文章

领域

  • 2篇医药卫生
  • 1篇生物学

主题

  • 2篇糖尿
  • 2篇糖尿病
  • 1篇循证
  • 1篇循证医学
  • 1篇遗传学
  • 1篇早发2型糖尿...
  • 1篇糖尿病流行病...
  • 1篇突变
  • 1篇流行病
  • 1篇流行病学
  • 1篇基因
  • 1篇基因测定
  • 1篇基因突变
  • 1篇分子
  • 1篇分子遗传学
  • 1篇NF-KB
  • 1篇NUCLEA...
  • 1篇TRANSC...
  • 1篇CREB
  • 1篇MODY

机构

  • 2篇中山大学附属...
  • 1篇中山大学

作者

  • 2篇翁建平
  • 1篇蔡梦茵
  • 1篇梁华
  • 1篇沈云峰
  • 1篇严晋华
  • 1篇余秋琼

传媒

  • 2篇中山大学学报...
  • 1篇Chines...

年份

  • 2篇2010
  • 1篇2009
3 条 记 录,以下是 1-3
排序方式:
中国早发2型糖尿病家系MODY 1-5基因测定被引量:5
2009年
【目的】通过对早发2型糖尿病家系先证者进行直接测序,寻找中国人群中可能存在的青少年的成人发病型糖尿病(MODY)1-5基因突变。【方法】对19个早发2型糖尿病家系的先证者进行MODY1-5基因扩增和DNA直接测序。【结果】19个先证者未发现MODY基因突变,但发现MODY1-5基因分别存在6、5、15、1、1种多态性。【结论】MODY相关基因突变具有种族异质性,MODY1-5基因突变不是该19个早发糖尿病家系的致病因素。
严晋华沈云峰余秋琼梁华蔡梦茵翁建平
关键词:早发2型糖尿病基因突变
对糖尿病流行病学、循证医学及基础研究的探索被引量:151
2010年
我国目前糖尿病正处于快速增长期,且糖尿病发病呈现年轻化趋势。本文就作者近年来在糖尿病领域的系列研究工作做一综述,主要涉及糖尿病及其相关疾病的流行病学、糖尿病的分子遗传学和2型糖尿病早期诊断治疗等。提倡对糖尿病患者进行个体化的诊断,实施个体化的治疗。
翁建平
关键词:糖尿病流行病学分子遗传学
Exchange of a nuclear corepressor between NF-kB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kB
2010年
Background NF-KB p65 was shown to inhibit transcription of phosphoenolpyruvate carboxykinase (PEPCK), a rate-limiting enzyme in gluconeogenesis in the liver. To understand the mechanism of action of NF-KB p65, we investigated the nuclear receptor corepressor in the regulation of PEPCK transcription. Methods Rat H411E cells, human hepatoma HepG2 cells and human embryo kidney (HEK) 293 cells were used in this study. The transcriptional activity of a rat PEPCK gene promoter (-490/+100) was analyzed in HepG2 cells, a HepG2 super suppressor IkBa (sslkBa) stable cell line, and HEK 293 cells. The effects of p65 and sslkBa on a rat PEPCK gene promoter were observed using the PEPCK luciferase reporter system. The interaction of the cAMP-response- element-binding (CREB) protein, histone deacetylase 3 (HDAC3) and silencing mediator for retinoic and thyroid hormone receptors (SMRT) with the PEPCK gene promoter were investigated using the chromatin immunoprecipitation (CHIP) assay, p65 cotransfection and RNAi-mediated gene knockdown were used to determine the corepressor involved in the inhibition of PEPCK by NF-KB p65 and the transcriptional regulation of CREB by NF-KB p65. Results NF-KB p65 inhibited PEPCK expression and the inhibition was blocked by sslkBa. The inhibitory effect of p65 was completely blocked in a HepG2 stable cell line in which sslkBa was expressed. HDAC3 or SMRT knockdown led to a significant up-regulation of PEPCK reporter activity in the presence of p65 cotransfection. In the ChIP assay the interaction of HDAC3 and SMRT with the PEPCK gene promoter was induced by p65 activation, but the CREB signal was reduced. Transcriptional activity of CREB was inhibited by NF-kB p65 cotransfection. The inhibitory effect of NF-kB p65 was blocked by HDAC3 RNAi or SMRT RNAi. Conculsions The study showed that the inhibition of PEPCK by NF-kB p65 was dependent on HDAC3 and SMRT, which form a nuclear corepressor complex for transcriptional inhibition. The transcription factors NF-kB p65 a
YAN Jin-huaGAO Zhan-guoYE Jian-pingWENG Jian-ping
共1页<1>
聚类工具0